{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,21]],"date-time":"2026-11-21T06:09:28Z","timestamp":1795241368027,"version":"4.10.3"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,28]],"date-time":"2022-11-28T00:00:00Z","timestamp":1669593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,28]],"date-time":"2022-11-28T00:00:00Z","timestamp":1669593600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["3G068619"],"award-info":[{"award-number":["3G068619"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["3G068619"],"award-info":[{"award-number":["3G068619"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background and objectives<\/jats:title>\n                    <jats:p>Defining the optimal moment to start renal replacement therapy (RRT) in acute kidney injury (AKI) remains challenging. Multiple randomized controlled trials (RCTs) addressed this question whilst using absolute criteria such as pH or serum potassium. However, there is a need for identification of the most optimal cut-offs of these criteria. We conducted a causal analysis on routinely collected data (RCD) to compare the impact of different pre-specified dynamic treatment regimes (DTRs) for RRT initiation based on time-updated levels of potassium, pH, and urinary output on 30-day ICU mortality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design, setting, participants, and measurements<\/jats:title>\n                    <jats:p>Patients in the ICU of Ghent University Hospital were included at the time they met KDIGO-AKI-stage \u2265\u20092. We applied inverse-probability-of-censoring-weighted Aalen\u2013Johansen estimators to evaluate 30-day survival under 81 DTRs prescribing RRT initiation under different thresholds of potassium, pH, or persisting oliguria.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Out of 13,403 eligible patients (60.8\u2009\u00b1\u200916.8\u00a0years, SOFA 7.0\u2009\u00b1\u20094.1), 5622 (63.4\u2009\u00b1\u200915.3\u00a0years, SOFA 8.2\u2009\u00b1\u20094.2) met KDIGO-AKI-stage \u2265\u20092. The DTR that delayed RRT until potassium \u2265\u20097\u00a0mmol\/l, persisting oliguria for 24\u201336\u00a0h, and\/or pH\u2009&lt;\u20097.0 (non-oliguric) or\u2009&lt;\u20097.2 (oliguric) despite maximal conservative treatment resulted in a reduced 30-day ICU mortality (from 12.7% [95% CI 11.9\u201313.6%] under current standard of care to 10.5% [95% CI 9.5\u201311.7%]; risk difference 2.2% [95% CI 1.3\u20133.8%]) with no increase in patients starting RRT (from 471 [95% CI 430\u2013511] to 475 [95% CI 342\u2013572]). The fivefold cross-validation benchmark for the optimal DTR resulted in 30-day ICU mortality of 10.7%.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our causal analysis of RCD to compare RRT initiation at different thresholds of refractory low pH, high potassium, and persisting oliguria identified a DTR that resulted in a decrease in 30-day ICU mortality without increase in number of RRTs. Our results suggest that the current criteria to start RRT as implemented in most RCTs may be suboptimal. However, as our analysis is hypothesis generating, this optimal DTR should ideally be validated in a multicentric RCT.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13054-022-04252-1","type":"journal-article","created":{"date-parts":[[2022,11,28]],"date-time":"2022-11-28T12:12:53Z","timestamp":1669637573000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Timing of dialysis in acute kidney injury using routinely collected data and dynamic treatment regimes"],"prefix":"10.1186","volume":"26","author":[{"given":"Pawe\u0142","family":"Morzywo\u0142ek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Steen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stijn","family":"Vansteelandt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Decruyenaere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sigrid","family":"Sterckx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wim","family":"Van Biesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,28]]},"reference":[{"key":"4252_CR1","first-page":"4263","volume":"27","author":"D Fliser","year":"2012","unstructured":"Fliser D, Laville M, Covic A, Fouque D, Vanholder R, Juillard L, Van Biesen W. A European renal best practice (ERBP) position statement on the kidney disease improving global outcomes (KDIGO) clinical practice guidelines on acute kidney injury: part 1: definitions, conservative management and contrast-induced nephropathy. Nephrol Dial Transpl Off Publ Eur Dial Transpl Assoc Eur Ren Assoc. 2012;27:4263\u201372.","journal-title":"Nephrol Dial Transpl Off Publ Eur Dial Transpl Assoc Eur Ren Assoc"},{"key":"4252_CR2","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/S0140-6736(13)60647-9","volume":"382","author":"NH Lameire","year":"2013","unstructured":"Lameire NH, Bagga A, Cruz D, De Maeseneer J, Endre Z, Kellum JA, Liu KD, Mehta RL, Pannu N, Van Biesen W, Vanholder R. Acute kidney injury: an increasing global concern. Lancet. 2013;382:170\u20139.","journal-title":"Lancet"},{"key":"4252_CR3","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1056\/NEJMoa2000741","volume":"383","author":"SM Bagshaw","year":"2020","unstructured":"Investigators, S-A, Canadian Critical Care Trials, G, Australian, New Zealand Intensive Care Society Clinical Trials, G, United Kingdom Critical Care Research, G, Canadian Nephrology Trials, N, Irish Critical Care Trials, G, Bagshaw SM, Wald R, Adhikari NKJ, Bellomo R, da Costa BR, Dreyfuss D, Du B, Gallagher MP, Gaudry S, Hoste EA, Lamontagne F, Joannidis M, Landoni G, Liu KD, McAuley DF, McGuinness SP, Neyra JA, Nichol AD, Ostermann M, Palevsky PM, Pettila V, Quenot JP, Qiu H, Rochwerg B, Schneider AG, Smith OM, Thome F, Thorpe KE, Vaara S, Weir M, Wang AY, Young P, Zarbock A. Timing of initiation of renal-replacement therapy in acute kidney injury. N Engl J Med. 2020;383:240\u201351.","journal-title":"N Engl J Med"},{"issue":"sup2","key":"4252_CR4","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1179\/acb.2007.077","volume":"62","author":"DM Vandijck","year":"2007","unstructured":"Vandijck DM, Oeyen S, Decruyenaere JM, Annemans L, Hoste EA. Acute kidney injury, length of stay, and costs in patients hospitalized in the intensive care unit. Acta Clin Belg Suppl. 2007;62(sup2):341\u20135.","journal-title":"Acta Clin Belg Suppl"},{"key":"4252_CR5","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1016\/S0140-6736(20)30531-6","volume":"395","author":"S Gaudry","year":"2020","unstructured":"Gaudry S, Hajage D, Benichou N, Chaibi K, Barbar S, Zarbock A, Lumlertgul N, Wald R, Bagshaw SM, Srisawat N, Combes A, Geri G, Jamale T, Dechartres A, Quenot JP, Dreyfuss D. Delayed versus early initiation of renal replacement therapy for severe acute kidney injury: a systematic review and individual patient data meta-analysis of randomised clinical trials. Lancet. 2020;395:1506\u201315.","journal-title":"Lancet"},{"key":"4252_CR6","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/S0140-6736(21)00350-0","volume":"397","author":"S Gaudry","year":"2021","unstructured":"Gaudry S, Hajage D, Martin-Lefevre L, Lebbah S, Louis G, Moschietto S, Titeca-Beauport D, Combe B, Pons B, de Prost N, Besset S, Combes A, Robine A, Beuzelin M, Badie J, Chevrel G, Bohe J, Coupez E, Chudeau N, Barbar S, Vinsonneau C, Forel JM, Thevenin D, Boulet E, Lakhal K, Aissaoui N, Grange S, Leone M, Lacave G, Nseir S, Poirson F, Mayaux J, Asehnoune K, Geri G, Klouche K, Thiery G, Argaud L, Rozec B, Cadoz C, Andreu P, Reignier J, Ricard JD, Quenot JP, Dreyfuss D. Comparison of two delayed strategies for renal replacement therapy initiation for severe acute kidney injury (AKIKI 2): a multicentre, open-label, randomised, controlled trial. Lancet. 2021;397:1293\u2013300.","journal-title":"Lancet"},{"key":"4252_CR7","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1056\/NEJMoa1603017","volume":"375","author":"S Gaudry","year":"2016","unstructured":"Gaudry S, Hajage D, Schortgen F, Martin-Lefevre L, Pons B, Boulet E, Boyer A, Chevrel G, Lerolle N, Carpentier D, de Prost N, Lautrette A, Bretagnol A, Mayaux J, Nseir S, Megarbane B, Thirion M, Forel JM, Maizel J, Yonis H, Markowicz P, Thiery G, Tubach F, Ricard JD, Dreyfuss D. Initiation strategies for renal-replacement therapy in the intensive care unit. N Engl J Med. 2016;375:122\u201333.","journal-title":"N Engl J Med"},{"key":"4252_CR8","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.1001\/jama.2016.5828","volume":"315","author":"A Zarbock","year":"2016","unstructured":"Zarbock A, Kellum JA, Schmidt C, Van Aken H, Wempe C, Pavenstadt H, Boanta A, Gerss J, Meersch M. Effect of early vs delayed initiation of renal replacement therapy on mortality in critically Ill patients with acute kidney injury: the ELAIN randomized clinical trial. JAMA J Am Med Assoc. 2016;315:2190\u20139.","journal-title":"JAMA J Am Med Assoc"},{"key":"4252_CR9","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1056\/NEJMoa1803213","volume":"379","author":"SD Barbar","year":"2018","unstructured":"Barbar SD, Clere-Jehl R, Bourredjem A, Hernu R, Montini F, Bruyere R, Lebert C, Bohe J, Badie J, Eraldi JP, Rigaud JP, Levy B, Siami S, Louis G, Bouadma L, Constantin JM, Mercier E, Klouche K, du Cheyron D, Piton G, Annane D, Jaber S, van der Linden T, Blasco G, Mira JP, Schwebel C, Chimot L, Guiot P, Nay MA, Meziani F, Helms J, Roger C, Louart B, Trusson R, Dargent A, Binquet C, Quenot JP. Investigators, I-IT, the, CTN: timing of renal-replacement therapy in patients with acute kidney injury and sepsis. N Engl J Med. 2018;379:1431\u201342.","journal-title":"N Engl J Med"},{"issue":"3","key":"4252_CR10","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1053\/j.ajkd.2021.07.014","volume":"79","author":"J Bouchard","year":"2022","unstructured":"Bouchard J, Mehta RL. Timing of kidney support therapy in acute kidney injury: What are we waiting for? Am J Kidney Dis Off J Natl Kidney Found. 2022;79(3):417\u201326. https:\/\/doi.org\/10.1053\/j.ajkd.2021.07.014.","journal-title":"Am J Kidney Dis Off J Natl Kidney Found."},{"key":"4252_CR11","unstructured":"Kidney disease: improving global outcomes (KDIGO) acute kidney injury work group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl 2012;2:1\u2013138."},{"key":"4252_CR12","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s13613-015-0093-5","volume":"5","author":"C Vinsonneau","year":"2015","unstructured":"Vinsonneau C, Allain-Launay E, Blayau C, Darmon M, Ducheyron D, Gaillot T, Honore PM, Javouhey E, Krummel T, Lahoche A, Letacon S, Legrand M, Monchi M, Ridel C, Robert R, Schortgen F, Souweine B, Vaillant P, Velly L, Osman D, Van Vong L. Renal replacement therapy in adult and pediatric intensive care\u202f: recommendations by an expert panel from the French Intensive Care Society (SRLF) with the French Society of Anesthesia Intensive Care (SFAR) French Group for Pediatric Intensive Care Emergencies (GFRUP) the French Dialysis Society (SFD). Ann Intensive Care. 2015;5:58.","journal-title":"Ann Intensive Care"},{"key":"4252_CR13","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1111\/sdi.12693","volume":"31","author":"J Vanmassenhove","year":"2018","unstructured":"Vanmassenhove J, Vanholder R, Van Biesen W, Lameire N. Haste makes waste-should current guideline recommendations for initiation of renal replacement therapy for acute kidney injury be changed? Semin Dial. 2018;31:204\u20138.","journal-title":"Semin Dial"},{"key":"4252_CR14","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1093\/aje\/kwv254","volume":"183","author":"MA Hernan","year":"2016","unstructured":"Hernan MA, Robins JM. Using big data to emulate a target trial when a randomized trial is not available. Am J Epidemiol. 2016;183:758\u201364.","journal-title":"Am J Epidemiol"},{"key":"4252_CR15","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s10654-017-0293-4","volume":"32","author":"JA Labrecque","year":"2017","unstructured":"Labrecque JA, Swanson SA. Target trial emulation: teaching epidemiology and beyond. Eur J Epidemiol. 2017;32:473\u20135.","journal-title":"Eur J Epidemiol"},{"key":"4252_CR16","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i4919","volume":"355","author":"JA Sterne","year":"2016","unstructured":"Sterne JA, Hernan MA, Reeves BC, Savovic J, Berkman ND, Viswanathan M, Henry D, Altman DG, Ansari MT, Boutron I, Carpenter JR, Chan AW, Churchill R, Deeks JJ, Hrobjartsson A, Kirkham J, Juni P, Loke YK, Pigott TD, Ramsay CR, Regidor D, Rothstein HR, Sandhu L, Santaguida PL, Schunemann HJ, Shea B, Shrier I, Tugwell P, Turner L, Valentine JC, Waddington H, Waters E, Wells GA, Whiting PF, Higgins JP. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016;355: i4919.","journal-title":"BMJ"},{"key":"4252_CR17","first-page":"2049","volume":"45","author":"V Didelez","year":"2016","unstructured":"Didelez V. Commentary: Should the analysis of observational data always be preceded by specifying a target experimental trial? Int J Epidemiol. 2016;45:2049\u201351.","journal-title":"Int J Epidemiol"},{"key":"4252_CR18","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1097\/EDE.0000000000000178","volume":"25","author":"ML Petersen","year":"2014","unstructured":"Petersen ML. Commentary: applying a causal road map in settings with time-dependent confounding. Epidemiology. 2014;25:898\u2013901.","journal-title":"Epidemiology"},{"key":"4252_CR19","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1093\/aje\/kwr249","volume":"174","author":"A Sjolander","year":"2011","unstructured":"Sjolander A, Nyren O, Bellocco R, Evans M. Comparing different strategies for timing of dialysis initiation through inverse probability weighting. Am J Epidemiol. 2011;174:1204\u201310.","journal-title":"Am J Epidemiol"},{"issue":"10","key":"4252_CR20","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1038\/s41591-019-0597-x","volume":"25","author":"BA Dickerman","year":"2019","unstructured":"Dickerman BA, Garcia-Albeniz X, Logan RW, Denaxas S, Hernan MA. Avoidable flaws in observational analyses: an application to statins and cancer. Nature Med. 2019;25(10):1601\u20136.","journal-title":"Nature Med"},{"issue":"2","key":"4252_CR21","doi-asserted-by":"publisher","first-page":"18","DOI":"10.2202\/1557-4679.1212","volume":"6","author":"LE Cain","year":"2010","unstructured":"Cain LE, Robins JM, Lanoy E, Logan R, Costagliola D, Hernan MA. When to start treatment? A systematic approach to the comparison of dynamic regimes using observational data. Int J Biostat. 2010;6(2):18. https:\/\/doi.org\/10.2202\/1557-4679.1212.","journal-title":"Int J Biostat."},{"issue":"3","key":"4252_CR22","first-page":"141","volume":"5","author":"OJS Aalen","year":"1978","unstructured":"Aalen OJS. An empirical transition matrix for non-homogeneous Markov chains based on censored observations. Scand J Stat. 1978;5(3):141\u201350.","journal-title":"Scand J Stat"},{"key":"4252_CR23","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1093\/aje\/kwz100","volume":"188","author":"S Lodi","year":"2019","unstructured":"Lodi S, Phillis A, Lundgren J, Logan R, Sharma S, Cole SR, Babiker A, Law M, Chu H, Byrne D, Horban A, Sterne JAC, Porter K, Sabin C, Costagliola D, Abgrall S, Gill J, Touloumi G, Pacheco AG, van Sighem A, Reiss P, Bucher HC, Montoliu Gimenez A, Jarrin I, Wittkop L, Meyer L, Perez-Hoyos S, Justice A, Neaton JD, Hernan MA, Group, ISS, the, HIVCC. Effect estimates in randomized trials and observational studies: comparing apples with apples. Am J Epidemiol. 2019;188:1569\u201377.","journal-title":"Am J Epidemiol"},{"key":"4252_CR24","doi-asserted-by":"publisher","first-page":"11089","DOI":"10.1038\/s41598-021-90646-0","volume":"11","author":"J Vanmassenhove","year":"2021","unstructured":"Vanmassenhove J, Steen J, Vansteelandt S, Morzywolek P, Hoste E, Decruyenaere J, Benoit D, Van Biesen W. The importance of the urinary output criterion for the detection and prognostic meaning of AKI. Sci Rep. 2021;11:11089.","journal-title":"Sci Rep"},{"key":"4252_CR25","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2021-066306","volume":"375","author":"EL Fu","year":"2021","unstructured":"Fu EL, Evans M, Carrero JJ, Putter H, Clase CM, Caskey FJ, Szymczak M, Torino C, Chesnaye NC, Jager KJ, Wanner C, Dekker FW, van Diepen M. Timing of dialysis initiation to reduce mortality and cardiovascular events in advanced chronic kidney disease: nationwide cohort study. BMJ. 2021;375: e066306.","journal-title":"BMJ"},{"issue":"26","key":"4252_CR26","doi-asserted-by":"publisher","first-page":"5250","DOI":"10.1002\/sim.9568","volume":"41","author":"PSJ Morzywolek","year":"2022","unstructured":"Morzywolek PSJ, Van Biesen W, Decruyenaere J, Van Steelandt S. On estimation and cross-validation of dynamic treatment regimes with competing risks. Stat Med. 2022;41(26):5250\u201375.","journal-title":"Stat Med"},{"key":"4252_CR27","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1002\/sim.8471","volume":"39","author":"JG Young","year":"2020","unstructured":"Young JG, Stensrud MJ, Tchetgen Tchetgen EJ, Hernan MA. A causal framework for classical statistical estimands in failure-time settings with competing events. Stat Med. 2020;39:1199\u2013236.","journal-title":"Stat Med"},{"key":"4252_CR28","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1038\/ki.2009.159","volume":"76","author":"J Bouchard","year":"2009","unstructured":"Bouchard J, Soroko SB, Chertow GM, Himmelfarb J, Ikizler TA, Paganini EP, Mehta RL. Fluid accumulation, survival and recovery of kidney function in critically ill patients with acute kidney injury. Kidney Int. 2009;76:422\u20137.","journal-title":"Kidney Int"},{"key":"4252_CR29","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s12882-016-0323-6","volume":"17","author":"R Claure-Del Granado","year":"2016","unstructured":"Claure-Del Granado R, Mehta RL. Fluid overload in the ICU: evaluation and management. BMC Nephrol. 2016;17:109.","journal-title":"BMC Nephrol"},{"key":"4252_CR30","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.kint.2018.11.047","volume":"96","author":"JL Vincent","year":"2019","unstructured":"Vincent JL. Fluid management in the critically ill. Kidney Int. 2019;96:52\u20137.","journal-title":"Kidney Int"},{"key":"4252_CR31","doi-asserted-by":"publisher","first-page":"598","DOI":"10.21037\/atm.2019.09.78","volume":"7","author":"SD Barbar","year":"2019","unstructured":"Barbar SD, Dargent A, Quenot JP. Initiation of renal replacement therapy in patients with septic acute kidney injury: Right timing or right patient? Ann Transl Med. 2019;7:598.","journal-title":"Ann Transl Med"},{"key":"4252_CR32","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1038\/ki.2009.479","volume":"77","author":"ED Siew","year":"2010","unstructured":"Siew ED, Matheny ME, Ikizler TA, Lewis JB, Miller RA, Waitman LR, Go AS, Parikh CR, Peterson JF. Commonly used surrogates for baseline renal function affect the classification and prognosis of acute kidney injury. Kidney Int. 2010;77:536\u201342.","journal-title":"Kidney Int"},{"key":"4252_CR33","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1136\/thx.2006.066837","volume":"62","author":"J Travers","year":"2007","unstructured":"Travers J, Marsh S, Williams M, Weatherall M, Caldwell B, Shirtcliffe P, Aldington S, Beasley R. External validity of randomised controlled trials in asthma: To whom do the results of the trials apply? Thorax. 2007;62:219\u201323.","journal-title":"Thorax"},{"key":"4252_CR34","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1111\/dme.12047","volume":"30","author":"C Saunders","year":"2013","unstructured":"Saunders C, Byrne CD, Guthrie B, Lindsay RS, McKnight JA, Philip S, Sattar N, Walker JJ, Wild SH. Scottish diabetes research network epidemiology, G: External validity of randomized controlled trials of glycaemic control and vascular disease: How representative are participants? Diabet Med J Br Diabet Assoc. 2013;30:300\u20138.","journal-title":"Diabet Med J Br Diabet Assoc"},{"key":"4252_CR35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pctr.0010009","volume":"1","author":"PM Rothwell","year":"2006","unstructured":"Rothwell PM. Factors that can affect the external validity of randomised controlled trials. PLoS Clin Trials. 2006;1: e9.","journal-title":"PLoS Clin Trials"},{"key":"4252_CR36","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1007\/s40273-015-0298-3","volume":"33","author":"A Gheorghe","year":"2015","unstructured":"Gheorghe A, Roberts T, Hemming K, Calvert M. Evaluating the generalisability of trial results: introducing a centre- and trial-level generalisability index. Pharmacoeconomics. 2015;33:1195\u2013214.","journal-title":"Pharmacoeconomics"},{"key":"4252_CR37","doi-asserted-by":"publisher","first-page":"R73","DOI":"10.1186\/cc4915","volume":"10","author":"EA Hoste","year":"2006","unstructured":"Hoste EA, Clermont G, Kersten A, Venkataraman R, Angus DC, De Bacquer D, Kellum JA. RIFLE criteria for acute kidney injury are associated with hospital mortality in critically ill patients: a cohort analysis. Crit Care. 2006;10:R73.","journal-title":"Crit Care"},{"issue":"7","key":"4252_CR38","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1159\/000518918","volume":"51","author":"L Van De Ginste","year":"2021","unstructured":"Van De Ginste L, Vanommeslaeghe F, Hoste EAJ, Kruse JM, Van Biesen W, Verbeke F. Patients with severe lactic acidosis in the intensive care unit: a retrospective study of contributing factors and impact of renal replacement therapy. Blood Purif. 2021;51(7):577\u201383.","journal-title":"Blood Purif"},{"key":"4252_CR39","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.annepidem.2016.08.016","volume":"26","author":"MA Hernan","year":"2016","unstructured":"Hernan MA. Does water kill? A call for less casual causal inferences. Ann Epidemiol. 2016;26:674\u201380.","journal-title":"Ann Epidemiol"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-022-04252-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13054-022-04252-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-022-04252-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,28]],"date-time":"2022-11-28T12:25:22Z","timestamp":1669638322000},"score":1,"resource":{"primary":{"URL":"https:\/\/ccforum.biomedcentral.com\/articles\/10.1186\/s13054-022-04252-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,28]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["4252"],"URL":"https:\/\/doi.org\/10.1186\/s13054-022-04252-1","relation":{},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,28]]},"assertion":[{"value":"8 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Committee of the University Hospital Ghent (EC nr 201-0705). All participants provided informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None of the authors has financial conflicts of interest for the concepts and data presented in this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"365"}}